Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07768813 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity

StatusRecruiting
PhasePhase 1
Started2026-09-02
View on ClinicalTrials.gov ↗
The main objective of this trial is to establish the bioequivalence of survodutide in a pre-filled syringe (reference product \[formulation A\]) and in a vial (test product \[formulation B2\]) in male and female trial participants who are healthy or otherwise healthy with overweight/obesity, following subcutaneous administration.

Amendment history 1 change detected by DataLookout

2026-09-10
notable
Recruitment opened
Trial Details
NCT Number NCT07768813
Lead Sponsor Boehringer Ingelheim
Conditions Healthy, Obesity
Enrollment 44 participants
Start Date 2026-09-02
Primary Completion 2026-12-08 (estimated)
Study Completion 2026-12-22 (estimated)
Updated on ClinicalTrials.gov 2026-09-09